Literature DB >> 16305946

Image guided tumour ablation.

A R Gillams1.   

Abstract

Several different technologies have been employed for the local ablation of tissue by thermal techniques. At the present time the most widely favoured technique is radiofrequency ablation (RFA) but developments in other techniques, e.g. microwave may change this. In many countries RFA or percutaneous ethanol injection (PEI) are accepted therapies for patients with Childs Pugh Class A or B cirrhosis and early hepatocellular carcinoma (HCC). Results for RFA in large series of patients with liver metastases from colon cancer are very promising. Five-year survival rates of 26% from the time of first ablation and 30% from the diagnosis of liver metastases for patients with limited (<6, <5 cm) liver disease who are not surgical candidates compares well with post resection series where 5-year survival rates vary between 29% and 39% in operable candidates. Sufficient experience has now been gained in lung and renal ablation to show that these are minimally invasive techniques which can produce effective tumour destruction with a limited morbidity. More novel areas for ablation such as adrenal or pelvic recurrence are being explored. International Cancer Imaging Society.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16305946      PMCID: PMC1665233          DOI: 10.1102/1470-7330.2005.0015

Source DB:  PubMed          Journal:  Cancer Imaging        ISSN: 1470-7330            Impact factor:   3.909


  60 in total

1.  Percutaneous radiofrequency ablation of malignancies in the lung.

Authors:  D E Dupuy; R J Zagoria; W Akerley; W W Mayo-Smith; P V Kavanagh; H Safran
Journal:  AJR Am J Roentgenol       Date:  2000-01       Impact factor: 3.959

2.  Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer.

Authors:  A R Gillams; W R Lees
Journal:  Dis Colon Rectum       Date:  2000-05       Impact factor: 4.585

Review 3.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.

Authors:  G D Dodd; M C Soulen; R A Kane; T Livraghi; W R Lees; Y Yamashita; A R Gillams; O I Karahan; H Rhim
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

4.  Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Authors:  S Giacchetti; B Perpoint; R Zidani; N Le Bail; R Faggiuolo; C Focan; P Chollet; J F Llory; Y Letourneau; B Coudert; F Bertheaut-Cvitkovic; D Larregain-Fournier; A Le Rol; S Walter; R Adam; J L Misset; F Lévi
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

5.  Percutaneous radio frequency ablation of small renal tumors: initial results.

Authors:  Christian P Pavlovich; McClellan M Walther; Peter L Choyke; Stephen E Pautler; Richard Chang; W Marston Linehan; Bradford J Wood
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

6.  Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

Authors:  T Livraghi; S N Goldberg; S Lazzaroni; F Meloni; T Ierace; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  2000-03       Impact factor: 11.105

7.  Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies.

Authors:  A S Pearson; F Izzo; R Y Fleming; L M Ellis; P Delrio; M S Roh; J Granchi; S A Curley
Journal:  Am J Surg       Date:  1999-12       Impact factor: 2.565

8.  Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases.

Authors:  T Livraghi; S N Goldberg; F Monti; A Bizzini; S Lazzaroni; F Meloni; S Pellicanò; L Solbiati; G S Gazelle
Journal:  Radiology       Date:  1997-01       Impact factor: 11.105

9.  Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.

Authors:  D Elias; T De Baere; T Smayra; J F Ouellet; A Roche; P Lasser
Journal:  Br J Surg       Date:  2002-06       Impact factor: 6.939

10.  Treatment of hepatocellular carcinoma with radiofrequency ablation: radiologic-histologic correlation during follow-up periods.

Authors:  Manabu Morimoto; Kazuya Sugimori; Kazuhito Shirato; Atsushi Kokawa; Naohiko Tomita; Takafumi Saito; Noriko Tanaka; Akinori Nozawa; Masamichi Hara; Hisahiko Sekihara; Hiroshi Shimada; Toshio Imada; Katsuaki Tanaka
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

View more
  12 in total

1.  Microwaves create larger ablations than radiofrequency when controlled for power in ex vivo tissue.

Authors:  A Andreano; Yu Huang; M Franca Meloni; Fred T Lee; Christopher Brace
Journal:  Med Phys       Date:  2010-06       Impact factor: 4.071

Review 2.  Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.

Authors:  Pete Anderson; Maritza Salazar-Abshire
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

3.  In vivo cell death mediated by synthetic ion channels.

Authors:  Bryan A Smith; Megan M Daschbach; Seth T Gammon; Shuzhang Xiao; Sarah E Chapman; Caroline Hudson; Mark Suckow; David Piwnica-Worms; George W Gokel; W Matthew Leevy
Journal:  Chem Commun (Camb)       Date:  2011-06-17       Impact factor: 6.222

Review 4.  Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma.

Authors:  Loukia S Poulou; Evanthia Botsa; Ioanna Thanou; Panayiotis D Ziakas; Loukas Thanos
Journal:  World J Hepatol       Date:  2015-05-18

5.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.

Authors:  Maria Franca Meloni; Anita Andreano; Paul F Laeseke; Tito Livraghi; Sandro Sironi; Fred T Lee
Journal:  Radiology       Date:  2009-08-25       Impact factor: 11.105

6.  Interventional radiology and the care of the oncology patient.

Authors:  Siobhan B O'Neill; Owen J O'Connor; Max F Ryan; Michael M Maher
Journal:  Radiol Res Pract       Date:  2011-03-29

7.  Terminology and reporting criteria for radiofrequency ablation of tumors in the scientific literature: systematic review of compliance with reporting standards.

Authors:  Tae Wook Kang; Hyunchul Rhim; Min Woo Lee; Young-sun Kim; Dongil Choi; Hyo Keun Lim
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

Review 8.  Interventional radiology in the elderly.

Authors:  Konstantinos Katsanos; Farhan Ahmad; Renato Dourado; Tarun Sabharwal; Andreas Adam
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

Review 9.  Radiofrequency ablation of pulmonary tumours: current status.

Authors:  Karin Steinke
Journal:  Cancer Imaging       Date:  2008-03-03       Impact factor: 3.909

Review 10.  New horizons in MR-controlled and monitored radiofrequency ablation of liver tumours.

Authors:  Alexandru Cernicanu; Matthieu Lepetit-Coiffé; Magalie Viallon; Sylvain Terraz; Christoph D Becker
Journal:  Cancer Imaging       Date:  2007-11-05       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.